Hyogo, Japan

Yuriko Fukata


Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 19(Granted Patents)


Location History:

  • Katoh-gun, JP (1998 - 1999)
  • Hyogo, JP (2003)

Company Filing History:


Years Active: 1998-2003

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Yuriko Fukata

Introduction

Yuriko Fukata is a prominent inventor based in Hyogo, Japan. She has made significant contributions to the field of immunology, particularly through her innovative patents. With a total of four patents to her name, Fukata's work focuses on developing therapeutic agents that address various immune system disorders.

Latest Patents

Fukata's latest patents include the development of activated immunoglobulin, which serves multiple therapeutic purposes. This activated immunoglobulin is particularly useful as an eosinophilia-suppressing agent, immunomodulating agent, and therapeutic agent for autoimmune diseases. The process involves admixing immunoglobulin with a histamine component and subsequently removing the histamine through various methods such as dialysis and chromatography. This innovative approach imparts unique pharmacological activities to the immunoglobulin, distinguishing it from conventional immunosuppressive agents. The activated immunoglobulin has shown promise in treating conditions like chronic rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis, as well as various immunodeficiency syndromes.

Career Highlights

Fukata is associated with Nippon Zoki Pharmaceutical Co., Ltd., where she continues to advance her research and development efforts. Her work has garnered attention for its potential to revolutionize treatments for autoimmune diseases and other immune-related conditions.

Collaborations

Fukata has collaborated with notable colleagues, including Haruo Yoshii and Mitsuru Naiki, to further her research initiatives.

Conclusion

Yuriko Fukata's innovative contributions to immunology highlight her role as a leading inventor in the field. Her patents not only demonstrate her expertise but also offer hope for improved therapeutic options for patients with immune system disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…